The FDA will call attention to the dangers of abuse and possible death, Reuters reports. Other warnings will be the risks to babies whose mothers take the medicines.
The labels will appear on the drugs:
“The FDA is invoking its authority to require safety labeling changes and postmarket studies to combat the misuse, abuse, addiction, overdose and death from these potent drugs that have harmed too many patients and devastated too many families and communities,” FDA Commissioner Margaret Hamburg said in a news release.
The FDA will require additional studies of opioid pain medication to assess risks of abuse, overdose, and death.